Minority men who have sex with other men (MSM), especially Hispanic/Latino and African American/Black men, account for most new HIV diagnoses but poor care uptake.
Minority men who have sex with other men (MSM), especially Hispanic/Latino and African American/Black men, account for most new HIV diagnoses, despite total diagnoses actually decreasing 2.3% (95% CI, 1.9%-2.8%) annually, according to the CDC’s most recent Morbidity and Mortality Weekly Report.
In 2015 alone, the HIV diagnosis rate was 9.3 times higher in Black MSM compared with White MSM. This group also accounted for more diagnoses compared with the other racial/ethnic MSM groups evaluated.
Overall, by the end of the study period, just over two-thirds (68.3%) were able to achieve viral suppression (viral load < 200 copies/mL) within 6 months and only 80.8% were linked to care in the month following their diagnosis. Both of these results came in “below target during 2018.”
Using data reported as of December 2019 to the National HIV Surveillance System for MSM who received their diagnoses from 2014 to 2018, this examination of race/ethnicity and age data from 2014 through 2018 shows that new HIV diagnoses increased each year by 2.2% (95% CI, 1.0%-3.4%) among Black MSM and 2.0% (95% CI, 0.6%-3.3%) among Hispanic MSM aged 25 to 34 years. For younger MSM (aged 13-19 years), no significant change for either group was seen.
All MSM lived in 1 of 33 jurisdictions reporting complete lab data on CD4 counts and viral load for the study period.
“These findings, albeit promising, warrant intensified preventions efforts for Black, Hispanic, and younger MSM,” the report noted.
Although additional analyses reveal disparities in the results among the racial groups (Black, Hispanic, White, other) and age ranges (13-19, 20-24, 25-34, 35-44, 45-54, > 55 years) evaluated, there were similarities as well:
The report stresses the need to intensify prevention efforts Black and Hispanic/Latino MSM, especially those in the youngest age range evaluated (13-19 years), as well as increasing the overall linkage to care and viral suppression.
“CDC encourages use of interventions that address social determinants of health that underlie the high risk for HIV infection among MSM of all races/ethnicities and ages,” the authors concluded. “Such interventions might help prevent HIV infection and eliminate racial/ethnic disparities in HIV infection among MSM.”
Limitations to their findings are 2-fold:
Reference
Jeffries WL 4th, Dailey AF, Jin C, Carter JW Jr, Scales L. Trends in diagnosis of HIV infection, linkage to medical care, and viral suppression among men who have sex with men, by race/ethnicity and age — 33 jurisdictions, United States, 2014–2018. MMWR Morb Mortal Wekly Rep. 2020;69(38):1337-1342. doi:10.15585/mmwr.mm6938a1
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
2 Commerce Drive
Cranbury, NJ 08512